SCP-8270
Euclid
~
medium confidence
SCP-8270
Expected annual
$810K
One-time setup
$423K
Annual recurring
$770K
Personnel
5
Initial one-time setup is primarily driven by lab fit-out and core equipment (~$423k). Recurring annual costs (~$770k baseline) are dominated by staff wages, per-sample forensic analyses and legal/cover management.
One-Time Capital Costs
Total: $423K
Annual Recurring Costs
Total: $770K/yr
Cost Scenarios
📊
Baseline
(baseline)
$770K/yr
Normal operational year with routine discovery rate (~1-3/week), usual per-sample analyses, routine research budget and steady staffing.
routine discoveries
no public exposure
standard research cadence
🚨
Minor Incident
$845K/yr
A surge in discovery rate or a short-term need for expanded testing (e.g., localized cluster or priority identification requests).
temporary spike in discoveries
targeted sequencing/isotope surge
increased retrieval overtime
🚨
Major Breach
$1.3M/yr
Off-site discoveries, public exposure, FOIA/legal action or contamination that requires emergency containment, heavy PR/legal response and rapid staffing/equipment surge.
public disclosure or media attention
large off-site find associated with civilians
regulatory/legal escalation
Personnel
5 total
| Role | Count | Notes |
|---|---|---|
| Forensic Odontologist | 1 | Full-time specialist for dental examinations and comparisons; salary included in staff_wages [#11]. |
| Laboratory Technician | 2 | Handle specimen preparation, PCR/STR workflows, imaging prep, and LIMS entry; salaries included in staff_wages [#11]. |
| Monitoring Analyst | 1 | Part-time/shift-shared position for CCTV/area audits and anomaly detection; salary included in staff_wages and security_monitoring [#18]. |
| Security Officer / MTF Agent | 1 | Assigned for retrieval tasking coordination and secure transport; base salary in staff_wages; overtime retrieval costs captured in logistics_and_transport [#17]. |
Confidence Notes
Estimates are based on detailed analyst ranges in the notes but many line items have wide ranges (outsourcing vs purchase choices, variable discovery rates, and discretionary research/legal spending). Uncertainty arises from whether advanced imaging is purchased or outsourced, actual sequencing/testing policy, and possible changes in discovery frequency.